Advertisement

ADVERTISEMENT

Ami Peltier

A Cost-Effectiveness Analysis of cTACE vs DEB-TACE
Interview
A Cost-Effectiveness Analysis of cTACE vs DEB-TACE
09/24/2020
IO Learning invited Nishita Kothary, MD, to discuss her 2020 Society of Interventional Radiology (SIR) abstract, “Comparison of Drug-Eluting Beads versus Conventional Transarterial Chemoembolization: A Cost-Effectiveness...
IO Learning invited Nishita Kothary, MD, to discuss her 2020 Society of Interventional Radiology (SIR) abstract, “Comparison of Drug-Eluting Beads versus Conventional Transarterial Chemoembolization: A Cost-Effectiveness...
IO Learning invited Nishita...
09/24/2020
IO Learning
CIO 2020 Best Posters: The EMERALD-1 Study
Interview
CIO 2020 Best Posters: The EMERALD-1 Study
11/06/2020
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at the Symposium for Clinical Interventional Oncology (CIO) and was designated as a “CIO Best...
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at the Symposium for Clinical Interventional Oncology (CIO) and was designated as a “CIO Best...
IO Learning spoke with Riccardo...
11/06/2020
IO Learning
The Tanzania Interventional Radiology Initiative: An Update From the Road2IR Global Outreach Program
Interview
The Tanzania Interventional Radiology Initiative: An Update From the Road2IR Global Outreach Program
09/18/2020
Road2IR began in 2018 as a collaboration between the Yale Department of Radiology and Biomedical Imaging and Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania. It soon grew to include the Emory Department of...
Road2IR began in 2018 as a collaboration between the Yale Department of Radiology and Biomedical Imaging and Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania. It soon grew to include the Emory Department of...
Road2IR began in 2018 as a...
09/18/2020
IO Learning
Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer Treatment: An Interview With Joseph J. Busch, Jr., MD
Interview
Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer Treatment: An Interview With Joseph J. Busch, Jr., MD
04/18/2020
Dr Busch is the owner of the Busch Center, an imaging center in Alpharetta, Georgia that is dedicated to the diagnosis and treatment of prostate cancer. He spoke with IO Learning about integrating the recently FDA-approved TULSA...
Dr Busch is the owner of the Busch Center, an imaging center in Alpharetta, Georgia that is dedicated to the diagnosis and treatment of prostate cancer. He spoke with IO Learning about integrating the recently FDA-approved TULSA...
Dr Busch is the owner of the...
04/18/2020
IO Learning
Promising Treatment Option for Unresectable Pleural Mesothelioma
Interview
Promising Treatment Option for Unresectable Pleural Mesothelioma
07/13/2020
IO Learning invited Bela Kis, MD, PhD, to discuss his 2020 Society of Interventional Radiology (SIR) Abstract of the Year, "Transarterial Chemoperfusion Treatment of Unresectable Pleural Mesothelioma: Interim Results of a Phase 2 Prospective...
IO Learning invited Bela Kis, MD, PhD, to discuss his 2020 Society of Interventional Radiology (SIR) Abstract of the Year, "Transarterial Chemoperfusion Treatment of Unresectable Pleural Mesothelioma: Interim Results of a Phase 2 Prospective...
IO Learning invited Bela Kis,...
07/13/2020
IO Learning
Dr Aguado
Interview
Transarterial Oncologic Interventions in Children
04/09/2021
Primary malignant liver tumors are rare in children, accounting for 1%-2% of all pediatric cancers. When chemotherapy fails, Y-90 TARE may offer an alternative therapy as a bridge to surgical resection or liver transplant or for palliation....
Primary malignant liver tumors are rare in children, accounting for 1%-2% of all pediatric cancers. When chemotherapy fails, Y-90 TARE may offer an alternative therapy as a bridge to surgical resection or liver transplant or for palliation....
Primary malignant liver tumors...
04/09/2021
IO Learning
Angio-CT: Why You Should Invest — Clinical, Operational, and Economic Perspectives From an Early Adopter
Interview
Angio-CT: Why You Should Invest — Clinical, Operational, and Economic Perspectives From an Early Adopter
12/22/2020
The Siemens Nexaris Angio-CT combines angiography with computed tomography systems in one environment for interventional procedures. IO Learning spoke with David Lacey, MD, an Interventional Radiologist at Iowa Methodist Medical Center. Dr...
The Siemens Nexaris Angio-CT combines angiography with computed tomography systems in one environment for interventional procedures. IO Learning spoke with David Lacey, MD, an Interventional Radiologist at Iowa Methodist Medical Center. Dr...
The Siemens Nexaris Angio-CT...
12/22/2020
IO Learning
Dr Isabel Newton
Podcast
The Interventional Initiative: A Conversation With Isabel Newton, MD, PhD
05/09/2022
Podcast interview with Isabel Newton, MD, PhD, Co-founder of the Interventional Initiative, a nonprofit foundation dedicated to engaging the public with credible and comprehensible information about minimally invasive, image-guided procedures.
Podcast interview with Isabel Newton, MD, PhD, Co-founder of the Interventional Initiative, a nonprofit foundation dedicated to engaging the public with credible and comprehensible information about minimally invasive, image-guided procedures.
Podcast interview with Isabel...
05/09/2022
IO Learning
Interview
Percutaneous Thermal Segmentectomy
06/02/2022
IO Learning spoke with Dr Pierleone Lucatelli, an interventional radiologist at the Policlinico Umberto I in Rome, Italy, regarding his recent study examining the combination of balloon-occluded MWA followed by balloon-occluded TACE in...
IO Learning spoke with Dr Pierleone Lucatelli, an interventional radiologist at the Policlinico Umberto I in Rome, Italy, regarding his recent study examining the combination of balloon-occluded MWA followed by balloon-occluded TACE in...
IO Learning spoke with Dr...
06/02/2022
IO Learning
Interview
Phase I First-in-Human Study on the Use of Embrace Liquid Embolic for the Treatment of Hypervascular Tumors
06/14/2022
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S....
06/14/2022
IO Learning

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use